The viruses that cause AIDS in humans, human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2), are members of the lentivirus subfamily of retroviruses. The lentivirus subfamily also includes related members from simians (simian immunodeficiency virus [SIV] ), as well as from sheep, goats, horses, cattle, and cats. On the basis of genetic sequence analysis, five discrete groups of SIV and HIV primate lentiviruses are now recognized (9, 15) . One unifying feature of all lentiviruses is the presence of additional genes not found in other subfamilies of retroviruses. Some of these auxiliary genes are essential for virus replication (e.g., tat and rev for HIV and SIV), while others are nonessential for virus replication. The nonessential auxiliary genes of the HIV-1 group are vif, vpr, vpu, and nef. The nonessential auxiliary genes of the SIV mac / HIV-2/SIV sm group are vif, vpr, vpx, and nef. The presence of these auxiliary genes is probably related to unique features of lentiviral infection, particularly the persistent unrelenting nature of lentiviral replication (for reviews, see references 10 and 11) .
Little is known about the relative importance and functional roles of the nonessential auxiliary genes. Except for vif, their study has been hampered by the absence of large, easily measurable, phenotypic effects in cultured cells resulting from mutation. Infection of rhesus monkeys (Macaca mulatta) with molecularly cloned SIV mac 239 provides a useful system for studying these genes since a disease very similar to AIDS in humans is reproducibly induced. The properties of this virus and the features of the disease have been well characterized, and the exact sequence of the cloned virus is known (18, 19, 23) . The usefulness of this approach has been illustrated by earlier studies with the nef gene. Deletion of nef from SIV mac 239 resulted in no detectable alteration in virus growth in a variety of standard cell culture systems, but the levels of replicating virus in vivo were dramatically diminished by at least 2 orders of magnitude (19) . The presence of a functional nef gene in SIV appears to be required for efficient virus replication in vivo and for disease progression (6, 19) . The critical importance of nef in vivo was further illustrated by the universal selection for revertants of an introduced stop codon by 2 weeks after infection of rhesus monkeys (19) . We now report the surprising properties of derivatives of SIV mac 239 with deletions in vpr and vpx. vpr and vpx are related genes (28, 29) . All five groups of primate lentiviruses contain at least one homolog of vpr/vpx (9, 11, 15) . The SIV mac /HIV-2/SIV sm group of primate lentiviruses is the only one to contain both vpr and vpx genes; the other four groups of primate lentiviruses contain only one such homolog. Although it is known that the vpr and vpx products are both virion associated (4, 13, 31, 32) , their functional roles have not been elucidated.
MATERIALS AND METHODS
Cells and viruses. COS-1 cells were maintained in Dulbecco modified Eagle medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco BRL, Grand Island, N.Y.). Virus stocks used for animal inoculations were produced by transient expression in COS-1 fibroblast cells. Cells were transfected with 3 g each of SphI-digested plasmids p239SpSp5Ј and p239SpE3Ј or mutant plasmids derived from them by using DEAE-dextran followed by incubation for 2.5 h in 80 M chloroquine (Sigma Chemical, St. Louis, Mo.) and shocking for 2.5 min with 10% dimethyl sulfoxide (Fisher Scientific Co., Fair Lawn, N.J.) (5) . The clones that were used are described in detail by Gibbs et al. (12) . The ⌬vpx clone that was used for the results shown in this report had a change in vif Asn-1853Asp. However, we have subsequently obtained similar results with two rhesus monkeys infected with SIV⌬vpx containing the parental Asn at vif position 185 as well as no other off-site changes (data not shown). At 3 days posttransfection, cell-free supernatants were collected and assayed for p27 gag antigen by using a commercially available antigen capture kit (Coulter Corp., Hialeah, Fla.) prior to inoculation into monkeys. CEMx174 cells were maintained in RPMI 1640 medium (Gibco BRL) supplemented with 10% heat-inactivated fetal bovine serum (Gibco BRL).
Western immunoblot analysis of virus preparations. CEMx174 cells were infected by transfection of cloned DNAs as described previously (12) . Cells were removed from 250 ml of culture by centrifugation 12 to 20 days following transfection, and the supernatant was filtered through a 0.45-m-pore-size filter. Virus contained within the supernatant was pelleted by centrifugation at 17,500 rpm for 3 h in a type 19 rotor. Virus pellets were resuspended in a small volume of 0.5% Triton X-100 in phosphate-buffered saline (PBS), and p27 gag antigen concentrations were determined.
Vpr-specific and Vpx-specific antisera were raised in rabbits by using recombinant ␤-galactosidase fusion proteins. Monoclonal antibody to SIV p27 was harvested from the FA 2 hybridoma cell line (27) . Virus preparations containing 100 ng of p27 were treated with Laemmli sample buffer and electrophoresed through a sodium dodecyl sulfate (SDS)-15% polyacrylamide gel. Proteins were transferred to an Immobilon-P membrane (Millipore, Bedford, Mass.). All incubations were performed at room temperature, and membranes were washed three times for 5 to 10 min between incubation steps. Membranes were blocked with 5% skim milk in PBS-0.4% Tween 20 for 1 h and then incubated with a 1:500 dilution of the rabbit sera in 5% skim milk in PBS-0.05% Tween 20 or FA 2 cell culture supernatant for 1 h. Dilution of secondary antibodies and detection were performed as described by the manufacturer of the enhanced chemiluminescence system (Amersham).
Infection of rhesus monkeys and measurement of antibody responses. All rhesus monkeys used in this study were inoculated by intravenous injection of virus produced by transient expression in COS-1 cells. All experimental animals were housed in accordance with the guidelines set by the Committee on Animals of the Harvard Medical School and by those of the Committee on the Care and Use of Laboratory Animals, National Research Council. At the intervals described in the text, heparinized blood samples were drawn. Plasma was separated by centrifugation and stored frozen at Ϫ70ЊC until needed. Thawed plasma was used at dilutions of 1:20 and either 1:100 or 1:200 for enzyme-linked immunosorbent assay (ELISA) reactivity to purified whole SIV mac as described previously (8) .
Virus load determinations. Peripheral blood mononuclear cells (PBMC) were obtained from whole heparinized blood by banding on lymphocyte separation medium (Organon Teknika, Durham, N.C.) according to the manufacturer's recommendations. PBMC were enumerated with a hemacytometer, and serial threefold dilutions were performed in duplicate beginning with 10 6 PBMC. PBMC dilutions were cocultured with 10 5 CEMx174 cells in a volume of 1 ml. On day 3, 1 ml of RPMI supplemented with 10% heat-inactivated fetal bovine serum was added. Cultures were split 1:2 twice weekly until day 21, when the cultures were assayed for virus production by antigen capture.
In situ hybridization. In situ hybridization for SIV was performed on formalinfixed, paraffin-embedded sections of lymph node mounted on Superfrost/plus slides (Fisher Scientific). The probe used was a combination of two plasmids: (i) a subclone of p239SpE3Ј, which contains tat, rev, env, nef, and a small part of the 3Ј long terminal repeat in PBS-, and (ii) p239SpSp5Ј, which contains gag, pol, vif, vpx, vpr, and the 5Ј long terminal repeat in PBS (18) . This combination provides essentially the entire SIV mac 239 genome. The probes were labeled with digoxigenin-dUTP by random priming (Boehringer Mannheim, Indianapolis, Ind.). Probe size and labeling were determined by electrophoresis, blotting, and immunostaining of the DNA with antidigoxigenin antibodies. Hybridization procedures were modifications of those previously described (26, 30) and were performed under denaturing conditions to localize both DNA and RNA. Probes were applied at 0.5 ng/l. The slides were placed in a humidified chamber; hybridization was performed overnight at 42ЊC. Following overnight hybridization, sections were washed and then immunostained by using an avidin-biotinhorseradish peroxidase complex technique (17, 24) . Briefly, tissue sections were incubated sequentially with an unlabeled polyclonal sheep antidigoxigenin antibody (Boehringer Mannheim) followed by biotinylated secondary antibody and then biotin-conjugated horseradish peroxidase (Vector Laboratories, Inc., Burlingame, Calif.). Diaminobenzidine served as the chromogen. As a negative control, sections were hybridized with plasmid pUC19 labeled with digoxigenin at the same time as the probes. In addition, as a negative control for the immunostaining, representative sections were processed identically by using equivalent concentrations of sheep gamma globulin in place of the primary antibody. Sections were then counterstained with Mayer's hematoxylin.
DNA sequence analysis of recovered virus. At 16 weeks postinoculation, virus was recovered from all infected animals by cocultivation with CEMx174 cells in vitro. Total cellular DNA was prepared for PCR amplification by the method of Higuchi (14) . Infected CEMx174 cells (6 ϫ 10 6 ) were washed with PBS, lysed in 1 ml of PCR buffer containing 10 mM Tris-HCl (pH 8.0), 50 mM KCl, 2.5 mM MgCl 2 , 0.45% Nonidet P-40, 0.45% Tween 20, 0.1 mg of gelatin per ml, and 60 g of proteinase K per ml, incubated at 56ЊC for 1 h, and then heated at 95ЊC for 10 min to inactivate the proteinase K. DNA was amplified with oligonucleotides 67 (GATGTCAGATCCCAGGGAGAGAAT at nucleotide 5811) and 32 (AAAGAGGGGAATTGTCGC at nucleotide 6715), using Taq DNA polymerase (Perkin-Elmer, Norwalk, Conn.), and ligated directly into the vector pCRII (InVitrogen, San Diego, Calif.). Three clones were amplified from virus recovered from each animal and sequenced in their entirety by using M13 sequencing primers (New England Biolabs, Beverley, Mass.). Animals used were 242-91 (wild-type infected), 318-90, 115-90, and 132-91 (⌬vpx infected), and 44-90 and 84-90 (⌬vpr infected). The Asn-1853Asp change in the vif open reading frame (12) was maintained in all 12 DNA sequences from animals infected with ⌬vpx virus, indicating a lack of strong selective pressure for the parental asparagine codon at this position.
RESULTS

Infection of rhesus monkeys with wild-type and mutant SIV.
Four rhesus monkeys in each group were experimentally infected with an amount of SIV⌬vpr, SIV⌬vpx, and SIV⌬vpx⌬vpr equivalent to 0.38 ng of p27 antigen produced transiently after transfection of COS-1 cells (5, 12) . These derivatives of SIV mac 239, with deletions of 101, 101, and 266 bp, respectively, were carefully constructed so as not to affect adjacent or overlapping reading frames or known splice donor or splice acceptor sites (12) . The relatively large size of the deletions and the fact that sequences immediately downstream of the deletion in the target gene are out of frame virtually ensure the absence of a functional gene product (12) . The nef reading frame was open in all of the mutant viruses (19) . Four rhesus monkeys were infected with wild-type, parental SIV mac 239/nef-open as controls.
Western blot analysis of virus preparations using Vpr-specific and Vpx-specific sera was used to verify appropriate protein expression in the mutants. Samples loaded on the gels were normalized by amount of p27 gag antigen. Vpr protein was detected in similar amounts in wild-type and ⌬vpx virus preparations (Fig. 1) . Vpx protein was detected in similar amounts in wild-type and ⌬vpr virus preparation (Fig. 1) . Conversely, as expected, Vpr protein was not detected in ⌬vpr and ⌬vpx⌬vpr virus preparations, and Vpx protein was not detected in ⌬vpx and ⌬vpx⌬vpr virus preparations.
Plasma antigenemia. All four rhesus monkeys in the control group and all four that received SIV⌬vpr showed a spike in plasma antigenemia by 2 weeks after infection ( Table 1 ). The average values at 2 weeks were 1.0 ng of p27 per ml in the control group and 1.25 ng of p27 per ml in monkeys that received SIV⌬vpr. Persistent plasma antigenemia was observed in one of the rhesus monkeys that received wild-type virus (242-91) and in two that received SIV⌬vpr (398-90 and 105-91). Only two of the four rhesus monkeys that received SIV⌬vpx had detectable plasma antigenemia at any of the times tested (Table 1 ). All four of the rhesus monkeys that received SIV⌬vpx clearly were infected since they all had clearly did become infected upon inoculation of SIV⌬vpx⌬vpr, and only one of these monkeys had detectable plasma antigenemia at one time point only (Table 1) . Virus loads. Virus burdens were evaluated by measuring the numbers of PBMC needed to recover SIV by cocultivation with CEMx174 cells in vitro (Fig. 2) . We have extensive previous experience with this measurement in rhesus monkeys infected with SIV mac 239. During the asymptomatic persistent infection stage, generally 1,000 to 20,000 PBMC are needed to recover SIV from rhesus monkeys infected with the parental SIV mac 239. This is quite similar to equivalent measurements made in people infected with HIV-1 (16) . The four control animals in the current study exhibited virus loads within this same range (Fig. 2 . Virus burdens in rhesus monkeys that received SIV⌬vpr were not significantly different from those that received wild-type virus (Fig. 2) . Virus burdens in animals that received SIV⌬vpx were consistently lower (Fig. 2) . In three of them, virus burdens were generally 2-to 10-fold lower than those in animals receiving SIV⌬vpr or wild-type virus; in one monkey that received SIV⌬vpx (318-90), 10 6 or more PBMC were consistently needed. It was very difficult to recover SIV in the two monkeys that were infected with SIV⌬vpx⌬vpr; SIV was only occasionally recovered when 10 6 PBMC were used.
Antibody responses. All animals other than 143-90 and 74-90 produced antibodies against SIV as determined by whole virus ELISA (Fig. 3) . As a group, animals infected with wildtype virus or SIV⌬vpr produced higher levels of binding antibodies, most likely in response to the higher levels of replicating virus in animals in these groups. Animals infected with SIV⌬vpx produced intermediate levels of antibodies, and animals infected with the double mutant SIV⌬vpx⌬vpr responded with the lowest levels of antibodies. Within each group, it appeared that the infected animals with the lowest antibody levels consistently manifested the highest levels of plasma antigenemia and the highest virus loads, suggesting that animals with strong antibody responses are able to better control virus replication in vivo.
Disease progression. Lymph node biopsies were obtained from two animals in each group at 1 and 2 weeks postinoculation and again from all animals that were still alive at 92 weeks postinfection. The biopsies were graded on the basis of previously described morphologic criteria (24) and examined for SIV nucleic acid by nonisotopic in situ hybridization (Table  2) . SIV-infected cells were most numerous in monkeys inoculated with SIV⌬vpr and wild-type virus. These same animals also had significant changes in lymph node morphology ( Table  2) . Of the lymph node biopsy samples taken from animals that received SIV⌬vpx, only those from one (animal 132-91) had virus detectable by in situ hybridization ( Table 2) . None of the animals inoculated with SIV⌬vpx⌬vpr had virus detectable by in situ hybridization.
Two animals inoculated with SIV mac 239, two inoculated with SIV⌬vpr, and two inoculated with SIV⌬vpx had to be euthanatized because of poor health during the course of this study. None of the animals inoculated with SIV⌬vpx⌬vpr have become ill. The animals that died all had generalized lymphoid depletion and other lesions commonly seen in SIV-induced AIDS (1-3, 20, 25) , including Pneumocystis carinii pneumonia, granulomatous encephalitis, giant cell lymphadenitis, lymphosarcoma, and opportunistic adenovirus infection (Table 3) . No consistent differences in pathology were apparent between groups. All animals had moderate or high numbers of SIVinfected cells in lymphoid tissues at the time of death (Table  3) .
Rhesus monkeys that received wild-type SIV and SIV⌬vpr showed similar progressive declines in CD4 ϩ lymphocyte concentrations (Table 4) . By 85 weeks postinfection, the numbers of CD4 ϩ cells in blood in three of the monkeys that received SIV⌬vpx had declined to 16.5 to 17.7% of total PBMC (Table  4) . In these monkeys, 2,743, 24,691, and 37,037 PBMC were needed to recover SIV when tested at week 81. In contrast, monkey 318-90 infected with SIV⌬vpx had 29.4% CD4 ϩ cells in PBMC at week 85, and SIV was not recovered at week 81 even when 10 6 PBMC were used. Rhesus monkeys that received SIV⌬vpx⌬vpr consistently had CD4 ϩ cell counts in the normal range (35 to 50%) throughout the course of infection (Table 4) .
Genetic analysis. The surprising phenotypes of the SIV⌬vpr and SIV⌬vpx infections, which were similar to that of wild-type virus, prompted us to evaluate the gene sequences present in infected monkeys. DNA was prepared from cells infected with SIV recovered at 16 weeks postinfection, viral DNA sequences spanning vpx-vpr were amplified by PCR, and individual clones were sequenced. Although individual point mutations were observed around the vpr/vpx region, the presence of the original deletions was confirmed in all cases. In no case did we observe any evidence for contamination of the deletion mutant virus with wild-type virus. Dosage effects. For wild-type SIV mac , virulence is independent of dose over at least a 10,000-fold range (7, 22) . Nonetheless, it remained a distinct possibility that the virulence of the ⌬vpx⌬vpr mutant could be dose dependent. Since the original inoculum of the ⌬vpx⌬vpr virus appeared to be near the border of infectivity, we inoculated a single rhesus monkey with a much higher dose. We used 2 ml of undiluted ⌬vpx⌬vpr supernatant from infected CEMx174 cells containing 308 ng of p27; this dose is 810 times larger than what was used for the original experiments. While SIV was recovered with as little as 37,000 PBMC at 2 weeks after infection, SIV either was not recovered or was recovered only when 10 6 PBMC were used at weeks 4, 6, and 8. Thus, the highly attenuated infection with ⌬vpx⌬vpr does not appear to be due to a lower infectivity titer of the inoculum.
DISCUSSION
The virulence of the vpr, vpx, and vprϩvpx deletion mutants in rhesus monkeys exactly parallels their growth properties in primary cultured cells in vitro (12) . The replication of the vpr deletion mutant in rhesus monkey primary PBMC and macrophage cultures was indistinguishable from that of the parental wild-type virus (12) , and this was reflected by a similar ability to cause CD4 declines, AIDS, and death in rhesus monkeys. The vpx deletion mutant was significantly reduced in its ability to replicate in primary cells (12) , and this was reflected by lower virus burdens and delayed but definite disease induction in rhesus monkeys. The vprϩvpx double mutant was severely retarded in its ability to replicate in primary rhesus monkey cells (but not in the CEMx174 cell line) in vitro (12) , and no evidence of disease progression was observed in infected animals. These correlations contrast markedly with the properties of the nef deletion mutant for which severe attenuation in vivo was not accompanied by reduced virus replication in primary cells in culture under the same conditions (19) . The decreased virulence of the vprϩvpx double mutant appears to be similar in severity to that of the nef deletion mutant. vpr and vpx are related genes, one of which probably arose from an ancestral gene duplication event (28, 29) . Unlike other auxiliary gene products, vpr and vpx are both virion associated. These observations suggest that the functional roles of these genes may be duplicative or overlapping in nature. The much greater attenuation of the vprϩvpx double mutant than either single mutant alone is consistent with this possibility. If their functions are indeed duplicative or overlapping, vpx would appear to be dominant, at least in the SIV mac 239 clone.
The uniform conservation of vpr in the SIV mac /HIV-2/SIV sm group indicates that its presence provides a selective advantage to virus. Using a different experimental design, Lang et al. (21) were able to demonstrate a facilitating effect of vpr in experimentally inoculated rhesus monkeys. Rhesus monkeys were infected with a variant form of SIV mac 239 with point mutations in both vpr and nef that eliminated expression of both of these genes. Within 8 weeks, reversions in vpr appeared in three of five animals. nef revertants were selected in a quicker time frame in all five animals. The specific reversion to an open form of vpr provides strong evidence for selective advantage contributed by vpr in inoculated rhesus monkeys. However, the selective advantage must be slight since virus with vpr deleted produces plasma antigenemia, virus loads, CD4 declines, and disease progression very similar to those of wild-type virus. Thus, the vpr gene of SIV mac 239 should probably not be considered as crucial to virus replication in vivo but rather as providing a slight facilitating advantage. 
